MODAVAR PHARMACEUTICALS LLC Email Format

Pharmaceutical ManufacturingDistrict of Columbia, United States11-50 Employees

Modavar Pharmaceuticals LLC operates as the United States subsidiary of the Cadila Pharmaceutical Group within the pharmaceutical manufacturing sector. It is based in Washington, DC, and functions as part of Cadila’s global network to produce prescription medicines. Cadila's manufacturing operations are conducted in compliance with current good manufacturing practices and have approvals from major regulators, underscoring a broad international footprint.

Modavar serves customers seeking contract manufacturing of prescription medicines, leveraging Cadila’s presence in seven countries, including the United States. The Cadila group emphasizes innovation and ethical standards in clinical research, with a focus on improving patient health worldwide, which frames Modavar’s activities around quality and compliance. A concrete development in 2023 was Modavar’s announcement of the launch of Paroxetine ER Tablets.

Get verified MODAVAR PHARMACEUTICALS LLC emails free

Company overview Employee directory